DrugPatentWatch Database Preview

Details for Patent: 8,088,934

Which drugs does patent 8,088,934 protect, and when does it expire?

Patent 8,088,934 protects AMITIZA and is included in one NDA.

This patent has thirty-nine patent family members in twenty-four countries.

Summary for Patent: 8,088,934

Title:	Composition and method for stabilizing the same
Abstract:	Disclosed is a novel composition comprising a novel bi-cyclic compound, which is expected to be pharmaceutically active, and a glyceride. The stability of the bi-cyclic compound can be improved significantly by dissolving the same in a glyceride.
Inventor(s):	Ueno; Ryuji (Montgomery, MD), Habe; Tsuyoshi (Sasayama, JP)
Assignee:	SUCAMPO AG (Zurich, CH)
Application Number:	12/144,000
Patent Claim Types: see list of patent claims	Compound;

Drugs Protected by US Patent 8,088,934

Glossary

This preview shows a limited data set. Subscribe for full access, or try a Free Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Patent Submitted
Sucampo Pharma Llc	AMITIZA	lubiprostone	CAPSULE;ORAL	021908-002	Apr 29, 2008		RX	Yes	No	➤ Sign Up	➤ Sign Up		Y			➤ Sign Up
Sucampo Pharma Llc	AMITIZA	lubiprostone	CAPSULE;ORAL	021908-001	Jan 31, 2006		RX	Yes	Yes	➤ Sign Up	➤ Sign Up		Y			➤ Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Patent Submitted

Non-Orange Book US Patents Family Members for Patent 8,088,934

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

This preview shows a limited data set. Subscribe for full access, or try a Free Trial
Patent No.	Title	Estimated Patent Expiration
8,097,649	Composition and method for stabilizing the same	➤ Sign Up
6,583,174	Composition and method for stabilizing the same	➤ Sign Up
7,417,067	Composition and method for stabilizing the same	➤ Sign Up
Patent No.	Title	Estimated Patent Expiration

International Patents Family Members for US Patent 8,088,934

This preview shows a limited data set. Subscribe for full access, or try a Free Trial
Country	Document Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Argentina	026046	➤ Sign Up
Argentina	089848	➤ Sign Up
Austria	267189	➤ Sign Up
Austria	402925	➤ Sign Up
Country	Document Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration

Summary for Patent: 8,088,934

For more information try a trial or see the plans and pricing